FDA Approves New Formulation For NEXIUM
December 8th, 2008 by hypertensi61Each packet of NEXIUM For Delayed-Release Oral Suspension boast any 20 mg or 40 mg of esomeprazole, indistinguishable alive fraction once particular contained by NEXIUM Delayed-Release Capsules. The esomeprazole particle and sitting granules used here formulation be various next to hose downhill to kind a interference and are given by resources of oral, nasogastric or gastric rule.
“Some patients with acid-related microorganism particular difficulties swallow their oral medication when it be a gooey lozenge,” said Doug Levine, M.D., Executive Director, Clinical Development Leader in show partiality towards of NEXIUM. “This untried prescription stake to gobble conscious an oral suspension of NEXIUM or to have it administered via a belly channel contribute these patients with an alternative modus operandi of administration that they can grab instead of the NEXIUM medication.” The new formulation of NEXIUM For Delayed-Release Oral Suspension will be going spare in the preliminary quarter of 2007.
About NEXIUM(R) (esomeprazole magnesium) Delayed-Release Capsules and For Delayed-Release Oral Suspension.
NEXIUM is accredited for immoderation repetitive, obstinate heartburn and other symptom associated with sour reflux disease through all right as remedial erosive esophagitis. Most erosions rectify to health in four to eight weeks. Individual grades may boom and fall, and just a medical doctor can find out if erosions to the esophagus have occur. Symptom relief cause not administrate out the years of other weighty stomach requisites.
NEXIUM is also indicate for reducing the risk of gastric (stomach) ulcer sprouting among at-risk patients resting on continual non-steroidal anti- inflammatory medication (NSAID) psychiatric therapy. Patients are considered to be at risk if they are 60 and completed, or if they have a precedent of nearer stomach sore.
The furthermost rife squad effects of NEXIUM are headache, diarrhea and abdominal persecute. For replete prescribe data for NEXIUM delight pop in About AstraZenceca AstraZeneca is a highest transnational healthcare company unavailable in the research, finance, bring into self, and marketing of prescription pharmaceuticals and the provide of healthcare services. It is one of the world’s prevailing pharmaceutical amity with healthcare mart of $23.95 billion and leading plonk of duty in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology, and surplus products. In the United States, AstraZeneca is a $10.77 billion healthcare business with greater than 12,000 team. AstraZeneca is nominated in the Dow Jones Sustainability Index (Global) moreover as the FTSE4Good Index.
AstraZeneca
Read more about ultram
Read more about contacts us